To investigate the role of BATF3-dependent DCs in a model of T-cell driven anti-tumor immunity, we took advantage of the highly immunogenic MC38 colon cancer xenograft model, which is known to be strictly controlled by both CD4+ and CD8+ T-cells. Here, CD4 is linked to malignant colon neoplasm.